Global Consumer Health Giant Haleon Predicts High-End Organic Revenue Growth in 2023

Haleon, the global leader in standalone consumer health business, has recently made a bold prediction about its financial prospects for the year 2023. The company, known for its extensive portfolio of non-prescription drugs, vitamins, and oral care products, anticipates organic revenue growth at the upper-end of its projections. Anticipated Revenue Growth Despite operating in a…

Read More

J&J’s Consumer Health Division, Kenvue, Announces IPO in Anticipation of Upcoming Spin-off

Johnson & Johnson’s consumer health unit, Kenvue, has recently made headlines by filing for its Initial Public Offering (IPO) ahead of a planned spin-off. This pivotal move marks an exciting chapter in the company’s story, setting the stage for what could be a significant shift in the pharmaceutical industry. The Kenvue Business Profile Kenvue, the…

Read More